PubMed Health⌕ Search

Biomedical subjects

G Nymand

Publications and source records attributed to G Nymand.

16 recordsLinked to original sources
PubMed1975

Complement fixing and lymphocytotoxic antibodies in serum of pregnant women at delivery. IV. Serology.

The paper concerns 275 sera of pregnant women at delivery containing complement fixing platelet antibodies (CFPAb) and/or lymphocytotoxic antibodies (LCTAb). 79 sera contained operationally monospecific antibodies against platelets and/or lymphocytes. 10 sera had only CFPAb, 4 of these were C-fix anti-A. 41 sera had CFPAb and LCTAb, 18 of these were monospecific against platelets and/or lymphocytes. In 224 sera only LCTAb could be demonstrated, 57 were monospecific. Furthermore in 8 of 258 primigravidae, screened for LCTAb 6 months post partum antibodies were detected. Generally the antibodies present at delivery had disappeared or narrowed, but in 3 cases the antibodies were detectable only in the postpartum sample.

Antibodies↗
PubMed1975

Complement-fixing and lymphocytotoxic antibodies in serum of pregnant women at delivery II. Clinical observations I.

Sera from 2,008 pregnant women were examined for the presence of complement-fixing platelet antibodies (CFPAb) and lymphocytotoxic antibodies (LCTAb). Women with antibodies in their serum were compared with women without antibodies. No clinical significance of CFPAb or LCTAb was found as regards pre-eclampsia, arterial hypertension, albuminuria, oedema, glucosuria, premature delivery, spontaneous onset of labor and abortion.

Abortion, Spontaneous↗
PubMed1975

Complement fixing and lymphocytotoxic antibodies in serum of pregnant women at delivery. III. Clinical observations.

The investigation comprised 2,008 pregnancies. Sera fnd lymphocytotoxic antibodies (LCTAb). 14 women had only CFPAb, 44 had CFPAb and LCTAb, 224 had only LCTAb. In 3 of 481 cord blood serum samples LCTAb were demonstrated. No cases of neutropenia or thrombocytopenia was observed. No association was found between CFPAb or LCTAb and stillbirth, birth defects, degree of bilirubinaemia, diseases of the newborn, or placental weight. It was suggested that the applied lymphocytotoxicity test detects both in vivo cytolytic antibodies and enhancing antibodies, which may explain the results.

Antibodies↗